Skip to main content
All lobbying filings

PHILIPS HOLDING USA, INC.

Lobbying for PHILIPS HOLDING USA INC.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Expenses
$470,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

H.R. 1219, Oral Health Products Inclusion Act (whole bill)

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)

FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD

 Bills named in this filing 9
  • H.R. 1219
    Oral Health Products Inclusion Act
  • S. 1399
    Health Tech Investment Act
  • H.R. 6197
    Health Tech Investment Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 4519
    Medical Device Electronic Labeling Act
  • H.R. 1539
    Medical Device Electronic Labeling Act
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem